Jemperli (dostarlimab)

**Product type:** Human Prescription Drug

**Active ingredient:** DOSTARLIMAB

**Strength:** 50 mg/mL

**Dosage form:** Injection

**Route:** Intravenous

**Labeler:** GlaxoSmithKline LLC

**Marketing category:** BLA (BLA761174)

**Pharmacologic class:** Programmed Death Receptor-1 Blocking Antibody [EPC], Programmed Death Receptor-1-directed Antibody Interactions [MoA]